Biotech | April 05, 2022
Vipergen’s DNA based drug discovery partnership with Theseus Pharma
Under the terms of the agreement, Vipergen will apply its in-living-cell DNA-encoded library (DEL) screening platform to discover novel small-molecule compounds that bind to a selected Theseus kinase target
